Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Coherent sees new laser as standard treatment for glaucoma:

This article was originally published in Clinica

Executive Summary

In a pilot study of its new Selecta 7000 laser, Coherent found that it reduced the pressure associated with open-angle glaucoma by 30% on the first day of treatment, and that the benefit lasted for one year of follow-up. These initial results have encouraged the company to believe its technique, selective laser traberculoplasty, could become a standard treatment. The company is to begin shipment of the laser outside the US and will pursue clinical investigations in the US and Japan.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT089427

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel